Skip to main content

GHP Investment Advisors, Inc.

Position in NVO — Novo Nordisk A S

CIK 1401561 Denver, CO

Position in NVO

as of Jun 30, 2026 · filed Jul 20, 2026
Position Value
$231,358
+$52,717 QoQ
Shares Held
4,826
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#975
of 1,348 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GHP Investment Advisors, Inc. holds $46,475,498 across 14 Drug Manufacturers - General names. NVO ranks #8 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
4,826 $231,358

All Filings in NVO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $231,358 4,826
2026-03-31 $178,641 4,861
2025-12-31 $348,324 6,846
2025-09-30 $264,742 4,771
2025-06-30 $329,294 4,771
2025-03-31 $331,298 4,771
2024-12-31 $407,562 4,738
2024-09-30 $542,959 4,560
2024-06-30 $670,021 4,694
2024-03-31 $585,504 4,560
2023-12-31 $471,732 4,560
2023-09-30 $414,686 4,560
2023-06-30 $368,972 2,280
2023-03-31 $362,839 2,280
2022-12-31 $316,018 2,335
2022-09-30 $232,636 2,335
2022-06-30 $254,060 2,280
2022-03-31 $263,965 2,377
2021-12-31 $255,360 2,280
2021-09-30 $218,902 2,280